Expanding Device Eligibility And Other Suggestions For CMS’s TCET Pathway
Executive Summary
Comments submitted by industry members about CMS’s TCET notice highlight the need for greater device eligibility and transparency for the pathway.
You may also be interested in...
AdvaMed Proposes Comprehensive Strategy for CMS To Encourage Access to AI and Software
AdvaMed released a report on tactics CMS could use to improve coverage for AI and software.
CMS Promises Actions To Support TCET Pathway
CMS has released a list of actions and guidance documents it plans to take to support the TCET pathway.
Market Fast Track Or Regulatory Trap? Consultant Ken Block On US FDA’s Breakthrough Devices Program
Ken Block of Ken Block Consulting weighs in on the FDA’s Breakthrough Devices Program, its implications for raising capital, achieving speedier market access, and inviting more intensive regulatory scrutiny in this interview with Medtech Insight.